Skip to main content Accessibility help
×
Home
Medically Unexplained Symptoms, Somatisation and Bodily Distress
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 20
  • Export citation
  • Recommend to librarian
  • Buy the print book

Book description

Medically unexplained symptoms and somatisation are the fifth most common reason for visits to doctors in the USA, and form one of the most expensive diagnostic categories in Europe. The range of disorders involved includes irritable bowel syndrome, chronic widespread pain and chronic fatigue syndrome. This book reviews the current literature, clarifies and disseminates clear information about the size and scope of the problem, and discusses current and future national and international guidelines. It also identifies barriers to progress and makes evidence-based recommendations for the management of medically unexplained symptoms and somatisation. Written and edited by leading experts in the field, this authoritative text defines international best practice and is an important resource for psychiatrists, clinical psychologists, primary care doctors and those responsible for establishing health policy.

Refine List

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Send to Kindle
  • Send to Dropbox
  • Send to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
×

Contents

  • 8 - Identification, assessment and treatment of individual patients
    pp 175-216
  • View abstract

    Summary

    This chapter considers three groups, medically unexplained symptoms, somatoform disorders, and functional somatic syndromes. Describing the nature of these groups, it talks about their prevalence in cross-sectional studies in primary, secondary care and population-based studies. Medically unexplained symptoms are very common both in the general population and in primary and secondary care, but at least in the first two settings most are transient. Systematic reviews of the prevalence of irritable bowel syndrome in population-based samples have indicated that the prevalence varies considerably with the definition of the syndrome. Functional somatic syndromes are also common but only some patients with these syndromes also have numerous somatic symptoms. There is little doubt that somatoform disorders, or bodily distress syndromes, are an important and challenging group of conditions that are expensive in terms of healthcare use and time missed from work.
  • 9 - Training
    pp 217-235
  • View abstract

    Summary

    This chapter discusses the terminology, stressing the difficulties of the words and concept of medically unexplained symptoms (MUS), and discussing the pros and cons of alternative terms. A fundamental problem with the concept underlying medically unexplained symptoms is the dualism it fosters. The chapter provides the empirical foundation of positive psychobehavioural descriptors, and refers to their suitability as diagnostic criteria in more detail. It has been shown that patients with chronic unexplained symptoms report a negative self-concept of being weak, not tolerating stress and not tolerating any physical challenges. Avoidance of physical activities was the most powerful discriminator between patients with somatic complaints needing medical help and feeling disabled, and those with somatic complaints but without healthcare needs or disability. An important conceptual issue concerns the influence on classification of the psychophysiological models for the experience of disabling bodily symptoms.
  • 10 - Achieving optimal treatment organisation in different countries
    pp 236-252
  • View abstract

    Summary

    This chapter provides an overview of the current state of evidence regarding treatment of medically unexplained symptoms, somatisation and the functional somatic syndromes. Both primary and secondary care studies have been performed to assess the efficacy of psychological interventions, most commonly cognitive behaviour therapy administered by a mental health professional, or antidepressants, prescribed by the patient's usual doctor. Thirteen trials evaluated cognitive behaviour therapy, five evaluated antidepressants, four the effect of a consultation letter to the general practitioner (GP) and three the training of GPs. The chapter reviews psychological treatments and the use of antidepressants. It uses three systematic reviews to provide an overview of the evidence of efficacy of interventions for functional somatic symptoms. The evidence is stronger for some pharmacological treatments than for psychological treatments partly because of the universal use of placebo tablets and the lack of an attention-placebo in psychological treatment trials.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Book summary page views

Total views: 0 *
Loading metrics...

* Views captured on Cambridge Core between #date#. This data will be updated every 24 hours.

Usage data cannot currently be displayed